How lymphoma happens in people with HIV
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
The first thing to understand is what HIV does not do. It does not infect the B-cells that become lymphoma, and it does not insert itself into their DNA.
What it does is more indirect and, it turns out, more than sufficient: it removes the guards and keeps the factory running at maximum for years.
Related pages: AIDS-related lymphoma
The bottom line
- HIV does not infect the malignant B-cells.
- Loss of CD4 T-cells impairs the CD8 T-cells that control EBV-infected B-cells.
- Chronic stimulation keeps B-cells dividing and mutating for years.
- Co-infection with EBV or KSHV supplies additional transforming signals.
- Why lymphoma risk stays elevated after immune reconstitution.
- Which of these mechanisms matters most in any given case.
The story, step by step
- 1. The guards ()
- 2. The overworked cell ()
- 3. The dangerous machinery ()
- 4. The passengers ()
- 5. Putting it together ()
What the evidence labels mean
Losing immune surveillance
What happens
The immune system routinely kills cells that are starting to go wrong, and that function depends on the cells HIV destroys.
What the research shows
- Most adults carry Epstein-Barr virus for life, held permanently in check inside a small number of B-cells.
- What holds it in check is a population of cytotoxic CD8 T-cells that recognize and kill any B-cell that starts expressing viral proteins.
- Those CD8 cells need help from CD4 T-cells to function and to be maintained, and CD4 cells are what HIV destroys.
- As CD4 counts fall, EBV-infected B-cells are no longer reliably eliminated, and clones can expand unchecked.
- The same mechanism explains lymphoma after organ transplantation, where immunosuppressive drugs produce the same loss of control.
Why it matters
This is one principle rather than two diseases: whenever T-cell surveillance fails, EBV-driven B-cell lymphomas appear.
What's still uncertain
- How much residual surveillance persists at any given CD4 count varies between individuals.
Read more
Next: The overworked cell
Chronic B-cell activation
What happens
The second mechanism is about what the B-cells themselves are doing during years of HIV infection.
What the research shows
- HIV proteins, including the envelope protein gp120, and a continuous flood of inflammatory signals drive widespread B-cell activation.
- Inflammatory cytokines including interleukin-6 and interleukin-10 are persistently elevated and act as growth signals for B-cells.
- The result is polyclonal activation: large numbers of B-cells proliferating at once, rather than a controlled response to one infection.
- People with untreated HIV often have raised immunoglobulin levels, which is this process visible on a blood test.
- More cells dividing more often means more opportunities for a mistake.
Why it matters
Lymphoma here is partly a numbers problem: billions of extra cell divisions, each with a small chance of a catastrophic error.
What's still uncertain
- Which cytokines matter most has been studied mainly in blood samples rather than in lymph node tissue.
Read more
- NCI: HIV infection and cancer riskGovernment
Next: The dangerous machinery
Why B-cells are uniquely exposed
What happens
B-cells are the only cells in the body that deliberately mutate their own DNA, and that is why they become lymphomas.
What the research shows
- In germinal centres inside lymph nodes, B-cells rewrite their antibody genes to improve the fit against a target.
- Two processes do this: somatic hypermutation, which introduces point mutations, and class-switch recombination, which cuts and rejoins DNA.
- Both are driven by an enzyme called AID, which deliberately damages DNA so it can be repaired differently.
- When this machinery is running constantly, as it is in chronic HIV infection, breaks sometimes get rejoined to the wrong chromosome.
- That produces translocations such as MYC moved next to the antibody gene promoter, which is the defining event in Burkitt lymphoma.
Why it matters
The genetic accident that causes these lymphomas happens inside a normal process that B-cells cannot do without.
What's still uncertain
- Why particular genes are involved repeatedly is partly explained by their position and activity in the genome.
Read more
- NCI: HIV infection and cancer riskGovernment
- OwieClear: The subtypesOwieClear
Next: The passengers
Oncogenic viruses already present
What happens
Two herpesviruses contribute directly, and both are common in the general population.
What the research shows
- Epstein-Barr virus is carried by most adults and is found in a proportion of these lymphomas ranging from around a third to essentially all, depending on the subtype.
- Kaposi sarcoma-associated herpesvirus, also called HHV-8, causes Kaposi sarcoma and is found in two rare lymphoma subtypes.
- Both viruses carry genes that mimic normal growth and survival signals, which is covered on the mechanisms page.
- Neither causes lymphoma in people with intact immunity, which is the point: the virus is necessary in some subtypes and never sufficient on its own.
- Hepatitis C has also been associated with lymphoma risk and is more common in some populations with HIV.
Why it matters
These viruses are passengers in most people's bodies for life. What changes in HIV is that nothing is watching them.
What's still uncertain
- The proportion of cases attributable to each virus differs between populations and subtypes.
Read more
- NCI: HIV infection and cancer riskGovernment
- OwieClear: How EBV hijacks your cellsOwieClear
Next: Putting it together
Four things at once
What happens
No single mechanism explains these lymphomas. They converge.
What the research shows
- Surveillance is lost, so abnormal B-cells are not eliminated.
- B-cells are chronically activated, so there are many more of them dividing.
- The mutation machinery is running, so genetic accidents accumulate.
- Oncogenic viruses supply additional growth and survival signals to cells that already have a genetic hit.
- This also explains why risk falls but does not disappear with treatment: antiretroviral therapy restores surveillance and reduces activation, without undoing damage already done.
Why it matters
Each mechanism alone is survivable. Together, over years, they produce the lymphomas described on these pages.
What's still uncertain
- The relative contribution of each pathway in an individual case cannot be determined.
Read more
- NCI: HIV infection and cancer riskGovernment
- OwieClear: The clinical paradigm shiftOwieClear
More plain-language reading
- OwieClear: How the viruses transform a B-cellOwieClear
- OwieClear: The subtypesOwieClear
- OwieClear: Preventing lymphoma in HIVOwieClear